(5) Treatment with an sGC-activator riociguat attenuated directly the adverse effects of jetlag model-induced cardiac hypertrophy, cardiac fibrosis, and cardiac diastolic dysfunction. This evidence concerns the gene SGCB and cardiac hypertrophy.